Velasquez M T, Han Wan S, Maronde R F
Clin Pharmacol Ther. 1979 Nov;26(5):555-61. doi: 10.1002/cpt1979265555.
Twenty patients with mild to moderate hypertension whose blood pressures were not adequately controlled by a thiazide diuretic were treated for 4 wk with metropolol. Normotension (diastolic pressure less than 90 mm Hg) or reduction in diastolic pressure of at least 10 mm Hg was achieved in 12 of the patients 1 wk after metoprolol (200 mg/day) was added to the hydrochlorothiazide (100 mg/day) regimen. In the other 8 patients, pressure reduction was attained with larger doses (300 to 400 mg/day) of metoprolol. After 1 wk of combined therapy, heart rate decreased by 11% (p less than 0.001) and plasma renin activity (PRA) decreased 48% (p less than 0.001). The individual changes in mean blood pressure did not correlate with either the premetoprolol PRA level (r = 0.14) or the changes in PRA after metoprolol (r = 0.03) but did correlate with steady-state metoprolol plasma levels (r = 0.61, p less than 0.01). Pressure and heart rate reductions were sustained during the last 3 wk of combined therapy but the PRA decrease did not persist; levels gradually rose to near control by the fourth week. Urinary sodium excretion was not consistently changed on metoprolol therapy.
20例轻度至中度高血压患者,其血压未被噻嗪类利尿剂充分控制,接受了4周的美托洛尔治疗。在氢氯噻嗪(100mg/天)治疗方案中加用美托洛尔(200mg/天)1周后,12例患者实现了血压正常(舒张压低于90mmHg)或舒张压至少降低10mmHg。另外8例患者,使用较大剂量(300至400mg/天)的美托洛尔实现了血压降低。联合治疗1周后,心率下降了11%(p<0.001),血浆肾素活性(PRA)下降了48%(p<0.001)。平均血压的个体变化与美托洛尔治疗前的PRA水平(r=0.14)或美托洛尔治疗后的PRA变化(r=0.03)均无相关性,但与美托洛尔稳态血浆水平相关(r=0.61,p<0.01)。联合治疗的最后3周内,血压和心率持续降低,但PRA的降低未持续;到第四周时,其水平逐渐升至接近对照水平。美托洛尔治疗期间,尿钠排泄没有持续变化。